Nephrol Dial Transplant (2002) 17: 2071-2076
© 2002 European Renal Association-European Dialysis and Transplant Association
Invited Comment
ESRD patients in 2001: global overview of patients, treatment modalities and development trends
Fresenius Medical Care, Bad Homburg, Germany
Keywords: demographics; end-stage renal disease; haemodialysis; peritoneal dialysis; prevalence; worldwide
| The first 150 words of the full text of this article appear below. |
Introduction
The number of patients treated for end-stage renal disease (ESRD) has demonstrated continuous growth since the establishment of dialysis as a life-sustaining therapy and advances in organ transplantation. This growth in ESRD patients is five times the world population growth (1.3%) and continues to grow beyond all early expectations, showing no sign of reaching a steady state within the next two decades. Reasons contributing to this growth are generally considered to be the globally ageing, multi-morbid population, higher life-expectancy of treated ESRD patients and increasing access of a generally younger patient population to treatment in countries in which access to date has been limited. Additionally, developments to either prevent renal disease or provide a superior and financially viable replacement therapy are not expected in the foreseeable future [1].
Over the years, data from renal registries have provided valuable information on renal patients. The first registry report of the
Methods
Results
Countries considered
Patients and treatment modality
Haemodialysis patients
Peritoneal dialysis patients
Discussion
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. van der Velde, N. Halbesma, F. T. de Charro, S. J.L. Bakker, D. de Zeeuw, P. E. de Jong, and R. T. Gansevoort Screening for Albuminuria Identifies Individuals at Increased Renal Risk J. Am. Soc. Nephrol., April 1, 2009; 20(4): 852 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Galach, A. Werynski, J. Waniewski, P. Freida, and B. Lindholm KINETIC ANALYSIS OF PERITONEAL FLUID AND SOLUTE TRANSPORT WITH COMBINATION OF GLUCOSE AND ICODEXTRIN AS OSMOTIC AGENTS Perit. Dial. Int., January 1, 2009; 29(1): 72 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Yang, S.-J. Hwang, and Taiwan Society of Nephrology Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3977 - 3982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Peppelenbosch, W. H. M. van Kuijk, N. D. Bouvy, F. M. van der Sande, and J. H. M. Tordoir Peritoneal dialysis catheter placement technique and complications NDT Plus, October 1, 2008; 1(suppl_4): iv23 - iv28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Furumatsu, Y. Nagasawa, T. Hamano, H. Iwatani, K. Iio, T. Shoji, T. Ito, Y. Tsubakihara, and E. Imai Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan Nephrol. Dial. Transplant., March 1, 2008; 23(3): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakamoto TELEMEDICINE SYSTEM FOR PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S21 - S26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yoshino, M. K. Kuhlmann, P. Kotanko, R. N. Greenwood, R. L. Pisoni, F. K. Port, K. J. Jager, P. Homel, H. Augustijn, F. T. de Charro, et al. International Differences in Dialysis Mortality Reflect Background General Population Atherosclerotic Cardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3510 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Ghods and S. Savaj Iranian Model of Paid and Regulated Living-Unrelated Kidney Donation Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1136 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mattman, S. Eintracht, T. Mock, G. Schick, D. W. Seccombe, R. M. Hurley, and C. T. White Estimating Pediatric Glomerular Filtration Rates in the Era of Chronic Kidney Disease Staging J. Am. Soc. Nephrol., February 1, 2006; 17(2): 487 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rutkowski Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe Nephrol. Dial. Transplant., January 1, 2006; 21(1): 4 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kuzminskis, E. Ziginskiene, and I. Arune Bumblyte A registry of haemodialysis patients and the progress of haemodialysis services in Lithuania Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2623 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Grassmann, S. Gioberge, S. Moeller, and G. Brown ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2587 - 2593. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fernandez-Aviles Introduction: Diagnostic and interventional procedures for coronary artery disease: implications for selection of contrast media Eur. Heart J. Suppl., August 1, 2005; 7(suppl_G): G1 - G3. [Full Text] [PDF]
|
|
|
|
|
|
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mircescu, D. Capsa, M. Covic, M. G. Caprioara, G. Gluhovschi, O. Golea, N. Ursea, L. Garneata, V. Cepoi, N. Constantinovici, et al. Nephrology and renal replacement therapy in Romania--transition still continues (Cinderella story revisited) Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2971 - 2980. [Abstract] [Full Text] [PDF]
|
|